Drug Shortage Report for APIDRA

Last updated on 2022-09-14 History
Report ID 168019
Drug Identification Number 02279479
Brand name APIDRA
Common or Proper name Apidra
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) INSULIN GLULISINE
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 5 cartridge in a pack
ATC code A10AB
ATC description INSULINS AND ANALOGUES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-08-25
Estimated end date 2022-09-14
Actual end date 2022-09-13
Shortage status Resolved
Updated date 2022-09-14
Company comments The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2022-09-14 English Compare
v4 2022-09-13 French Compare
v3 2022-09-13 English Compare
v2 2022-08-26 French Compare
v1 2022-08-26 English Compare

Showing 1 to 5 of 5